RZLT logo

Rezolute, Inc.

RZLT
Healthcare|Biotechnology|US
$3.88
+0.24 (+6.59%)
DCF Value
$0.05
Tangible Book / Share
$0.82
Cash / Share
$0.86
Next Earnings Report
Feb 11, 2027
EPS est. -$0.16 · Revenue est. $1.2M
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Sep 2027
Est. completion
P3Tumor Hyperinsulinism (Tumor HI)
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
NCT06881992n=16

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Nov 2025
P3
RZ358 Treatment for Congenital Hyperinsulinism
NCT06208215

Recent Press Releases

Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update
Nov 5, 2026 · GlobeNewsWire
Rezolute to Participate in Upcoming Investor Conferences
Nov 2, 2026 · GlobeNewsWire
Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Oct 14, 2026 · GlobeNewsWire
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
Oct 5, 2026 · GlobeNewsWire
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
Sep 24, 2026 · GlobeNewsWire
Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
Sep 9, 2026 · GlobeNewsWire
Rezolute to Participate in Upcoming Investor Conferences
Sep 2, 2026 · GlobeNewsWire

SEC Filings (73)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 2026S-3Shelf registrationDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 29, 20268-KMaterial eventDocumentIndex
Oct 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Oct 7, 2026PRE 14AProxy / shareholder voteDocumentIndex
Oct 5, 20268-KMaterial eventDocumentIndex
Sep 24, 202610-KAnnual reportDocumentIndex
Sep 24, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 2, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
May 11, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 24, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 12, 202610-QQuarterly reportDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Feb 11, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 7, 20268-KMaterial eventDocumentIndex
Dec 19, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 18, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 5, 2025S-3ASRShelf registrationDocumentIndex
Nov 21, 2025S-8Employee stock planDocumentIndex
Nov 21, 20258-KMaterial eventDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 21, 20258-KMaterial eventDocumentIndex
Oct 17, 2025SC 13GPassive 5%+ stakeDocumentIndex
Oct 7, 2025DEF 14AProxy / shareholder voteDocumentIndex